These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38104236)

  • 41. Non-Ionotropic NMDA Receptor Signaling Drives Activity-Induced Dendritic Spine Shrinkage.
    Stein IS; Gray JA; Zito K
    J Neurosci; 2015 Sep; 35(35):12303-8. PubMed ID: 26338340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ifenprodil Improves Long-Term Neurologic Deficits Through Antagonizing Glutamate-Induced Excitotoxicity After Experimental Subarachnoid Hemorrhage.
    Sun JY; Zhao SJ; Wang HB; Hou YJ; Mi QJ; Yang MF; Yuan H; Ni QB; Sun BL; Zhang ZY
    Transl Stroke Res; 2021 Dec; 12(6):1067-1080. PubMed ID: 33713028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
    Kumar G; Patnaik R
    Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
    Mony L; Kew JN; Gunthorpe MJ; Paoletti P
    Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
    Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
    Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GluN2A-NMDA receptor-mediated sustained Ca
    Deep SN; Mitra S; Rajagopal S; Paul S; Poddar R
    J Biol Chem; 2019 Jul; 294(29):11154-11165. PubMed ID: 31167782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
    Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
    Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
    Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
    J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repurposing of cefpodoxime proxetil as potent neuroprotective agent through computational prediction and in vitro validation.
    Quan J; Ma C; Wang Y; Hu B; Zhang D; Zhang Z; Wang J; Cheng M
    J Biomol Struct Dyn; 2021 Jul; 39(11):3975-3985. PubMed ID: 32448083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers.
    Costa RO; Lacor PN; Ferreira IL; Resende R; Auberson YP; Klein WL; Oliveira CR; Rego AC; Pereira CM
    Aging Cell; 2012 Oct; 11(5):823-33. PubMed ID: 22708890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
    Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
    Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-Methyl-d-Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia.
    Rahman T; Purves-Tyson T; Geddes AE; Huang XF; Newell KA; Weickert CS
    Schizophr Res; 2022 Feb; 240():61-70. PubMed ID: 34952289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A conserved structural mechanism of NMDA receptor inhibition: A comparison of ifenprodil and zinc.
    Sirrieh RE; MacLean DM; Jayaraman V
    J Gen Physiol; 2015 Aug; 146(2):173-81. PubMed ID: 26170175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways.
    Rittase WB; Dong Y; Barksdale D; Galdzicki Z; Bausch SB
    Mol Cell Neurosci; 2014 May; 60():63-71. PubMed ID: 24769103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allosteric regulation in NMDA receptors revealed by the genetically encoded photo-cross-linkers.
    Tian M; Ye S
    Sci Rep; 2016 Oct; 6():34751. PubMed ID: 27713495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis.
    Szychowski KA; Wnuk A; Rzemieniec J; Kajta M; Leszczyńska T; Wójtowicz AK
    Mol Neurobiol; 2019 Jan; 56(1):1-12. PubMed ID: 29675573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.
    Xu Q; Hu M; Li J; Ma X; Chu Z; Zhu Q; Zhang Y; Zhu P; Huang Y; He G
    Eur J Med Chem; 2022 Jan; 227():113876. PubMed ID: 34710748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.